Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) SHH

29.82

+0.15(+0.51%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap5.77B
Enterprise Value2.85B
P/E Ratio-10.47
PEG Ratio1.14
Price/Sales Ratio6.9
Price/Book Ratio0.93
Enterprise/Revenue4.18
Enterprise/EBITDA-5.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.69
Operating Margin-0.81

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue827.92M
Revenue/Share4.12
Gross Profit262.79M
EBITDA-359.68M
Net Income-529.02M
Diluted EPS-2.6

Balance Sheet

Total Cash2.93B
Total Cash/Share14.48
Total Debt333.15M
Total Debt/Equity0.05
Current Ratio4.04
Book Value Per Share32.9

Price History

52-Week Change1.43
52-Week High41.49
52-Week Low21.14
Moving Average 50 Days27.74
Moving Average 200 Days28.23

Statistics

Average Volume3.38M
Shares Outstanding193.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor6:5
Last Split DateJune 26, 2023